Cargando…
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969671/ https://www.ncbi.nlm.nih.gov/pubmed/36849943 http://dx.doi.org/10.1186/s12885-023-10662-3 |
| _version_ | 1784897779883048960 |
|---|---|
| author | Karacin, Cengiz Oksuzoglu, Berna Demirci, Ayşe Keskinkılıç, Merve Baytemür, Naziyet Köse Yılmaz, Funda Selvi, Oğuzhan Erdem, Dilek Avşar, Esin Paksoy, Nail Demir, Necla Göksu, Sema Sezgin Türker, Sema Bayram, Ertuğrul Çelebi, Abdüssamet Yılmaz, Hatice Kuzu, Ömer Faruk Kahraman, Seda Gökmen, İvo Sakin, Abdullah Alkan, Ali Nayır, Erdinç Uğraklı, Muzafer Acar, Ömer Ertürk, İsmail Demir, Hacer Aslan, Ferit Sönmez, Özlem Korkmaz, Taner Celayir, Özde Melisa Karadağ, İbrahim Kayıkçıoğlu, Erkan Şakalar, Teoman Öktem, İlker Nihat Eren, Tülay Erul, Enes Mocan, Eda Eylemer Kalkan, Ziya Yıldırım, Nilgün Ergün, Yakup Akagündüz, Baran Karakaya, Serdar Kut, Engin Teker, Fatih Demirel, Burçin Çakan Karaboyun, Kubilay Almuradova, Elvina Ünal, Olçun Ümit Oyman, Abdilkerim Işık, Deniz Okutur, Kerem Öztosun, Buğra Gülbağcı, Burcu Belen Kalender, Mehmet Emin Şahin, Elif Seyyar, Mustafa Özdemir, Özlem Selçukbiricik, Fatih Kanıtez, Metin Dede, İsa Gümüş, Mahmut Gökmen, Erhan Yaren, Arzu Menekşe, Serkan Ebinç, Senar Aksoy, Sercan İmamoğlu, Gökşen İnanç Altınbaş, Mustafa Çetin, Bülent Uluç, Başak Oyan Er, Özlem Karadurmuş, Nuri Erdoğan, Atike Pınar Artaç, Mehmet Tanrıverdi, Özgür Çiçin, İrfan Şendur, Mehmet Ali Nahit Oktay, Esin Bayoğlu, İbrahim Vedat Paydaş, Semra Aydıner, Adnan Salim, Derya Kıvrak Geredeli, Çağlayan Yavuzşen, Tuğba Doğan, Mutlu Hacıbekiroğlu, İlhan |
| author_facet | Karacin, Cengiz Oksuzoglu, Berna Demirci, Ayşe Keskinkılıç, Merve Baytemür, Naziyet Köse Yılmaz, Funda Selvi, Oğuzhan Erdem, Dilek Avşar, Esin Paksoy, Nail Demir, Necla Göksu, Sema Sezgin Türker, Sema Bayram, Ertuğrul Çelebi, Abdüssamet Yılmaz, Hatice Kuzu, Ömer Faruk Kahraman, Seda Gökmen, İvo Sakin, Abdullah Alkan, Ali Nayır, Erdinç Uğraklı, Muzafer Acar, Ömer Ertürk, İsmail Demir, Hacer Aslan, Ferit Sönmez, Özlem Korkmaz, Taner Celayir, Özde Melisa Karadağ, İbrahim Kayıkçıoğlu, Erkan Şakalar, Teoman Öktem, İlker Nihat Eren, Tülay Erul, Enes Mocan, Eda Eylemer Kalkan, Ziya Yıldırım, Nilgün Ergün, Yakup Akagündüz, Baran Karakaya, Serdar Kut, Engin Teker, Fatih Demirel, Burçin Çakan Karaboyun, Kubilay Almuradova, Elvina Ünal, Olçun Ümit Oyman, Abdilkerim Işık, Deniz Okutur, Kerem Öztosun, Buğra Gülbağcı, Burcu Belen Kalender, Mehmet Emin Şahin, Elif Seyyar, Mustafa Özdemir, Özlem Selçukbiricik, Fatih Kanıtez, Metin Dede, İsa Gümüş, Mahmut Gökmen, Erhan Yaren, Arzu Menekşe, Serkan Ebinç, Senar Aksoy, Sercan İmamoğlu, Gökşen İnanç Altınbaş, Mustafa Çetin, Bülent Uluç, Başak Oyan Er, Özlem Karadurmuş, Nuri Erdoğan, Atike Pınar Artaç, Mehmet Tanrıverdi, Özgür Çiçin, İrfan Şendur, Mehmet Ali Nahit Oktay, Esin Bayoğlu, İbrahim Vedat Paydaş, Semra Aydıner, Adnan Salim, Derya Kıvrak Geredeli, Çağlayan Yavuzşen, Tuğba Doğan, Mutlu Hacıbekiroğlu, İlhan |
| author_sort | Karacin, Cengiz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9969671 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99696712023-02-28 Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy Karacin, Cengiz Oksuzoglu, Berna Demirci, Ayşe Keskinkılıç, Merve Baytemür, Naziyet Köse Yılmaz, Funda Selvi, Oğuzhan Erdem, Dilek Avşar, Esin Paksoy, Nail Demir, Necla Göksu, Sema Sezgin Türker, Sema Bayram, Ertuğrul Çelebi, Abdüssamet Yılmaz, Hatice Kuzu, Ömer Faruk Kahraman, Seda Gökmen, İvo Sakin, Abdullah Alkan, Ali Nayır, Erdinç Uğraklı, Muzafer Acar, Ömer Ertürk, İsmail Demir, Hacer Aslan, Ferit Sönmez, Özlem Korkmaz, Taner Celayir, Özde Melisa Karadağ, İbrahim Kayıkçıoğlu, Erkan Şakalar, Teoman Öktem, İlker Nihat Eren, Tülay Erul, Enes Mocan, Eda Eylemer Kalkan, Ziya Yıldırım, Nilgün Ergün, Yakup Akagündüz, Baran Karakaya, Serdar Kut, Engin Teker, Fatih Demirel, Burçin Çakan Karaboyun, Kubilay Almuradova, Elvina Ünal, Olçun Ümit Oyman, Abdilkerim Işık, Deniz Okutur, Kerem Öztosun, Buğra Gülbağcı, Burcu Belen Kalender, Mehmet Emin Şahin, Elif Seyyar, Mustafa Özdemir, Özlem Selçukbiricik, Fatih Kanıtez, Metin Dede, İsa Gümüş, Mahmut Gökmen, Erhan Yaren, Arzu Menekşe, Serkan Ebinç, Senar Aksoy, Sercan İmamoğlu, Gökşen İnanç Altınbaş, Mustafa Çetin, Bülent Uluç, Başak Oyan Er, Özlem Karadurmuş, Nuri Erdoğan, Atike Pınar Artaç, Mehmet Tanrıverdi, Özgür Çiçin, İrfan Şendur, Mehmet Ali Nahit Oktay, Esin Bayoğlu, İbrahim Vedat Paydaş, Semra Aydıner, Adnan Salim, Derya Kıvrak Geredeli, Çağlayan Yavuzşen, Tuğba Doğan, Mutlu Hacıbekiroğlu, İlhan BMC Cancer Correction BioMed Central 2023-02-27 /pmc/articles/PMC9969671/ /pubmed/36849943 http://dx.doi.org/10.1186/s12885-023-10662-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Karacin, Cengiz Oksuzoglu, Berna Demirci, Ayşe Keskinkılıç, Merve Baytemür, Naziyet Köse Yılmaz, Funda Selvi, Oğuzhan Erdem, Dilek Avşar, Esin Paksoy, Nail Demir, Necla Göksu, Sema Sezgin Türker, Sema Bayram, Ertuğrul Çelebi, Abdüssamet Yılmaz, Hatice Kuzu, Ömer Faruk Kahraman, Seda Gökmen, İvo Sakin, Abdullah Alkan, Ali Nayır, Erdinç Uğraklı, Muzafer Acar, Ömer Ertürk, İsmail Demir, Hacer Aslan, Ferit Sönmez, Özlem Korkmaz, Taner Celayir, Özde Melisa Karadağ, İbrahim Kayıkçıoğlu, Erkan Şakalar, Teoman Öktem, İlker Nihat Eren, Tülay Erul, Enes Mocan, Eda Eylemer Kalkan, Ziya Yıldırım, Nilgün Ergün, Yakup Akagündüz, Baran Karakaya, Serdar Kut, Engin Teker, Fatih Demirel, Burçin Çakan Karaboyun, Kubilay Almuradova, Elvina Ünal, Olçun Ümit Oyman, Abdilkerim Işık, Deniz Okutur, Kerem Öztosun, Buğra Gülbağcı, Burcu Belen Kalender, Mehmet Emin Şahin, Elif Seyyar, Mustafa Özdemir, Özlem Selçukbiricik, Fatih Kanıtez, Metin Dede, İsa Gümüş, Mahmut Gökmen, Erhan Yaren, Arzu Menekşe, Serkan Ebinç, Senar Aksoy, Sercan İmamoğlu, Gökşen İnanç Altınbaş, Mustafa Çetin, Bülent Uluç, Başak Oyan Er, Özlem Karadurmuş, Nuri Erdoğan, Atike Pınar Artaç, Mehmet Tanrıverdi, Özgür Çiçin, İrfan Şendur, Mehmet Ali Nahit Oktay, Esin Bayoğlu, İbrahim Vedat Paydaş, Semra Aydıner, Adnan Salim, Derya Kıvrak Geredeli, Çağlayan Yavuzşen, Tuğba Doğan, Mutlu Hacıbekiroğlu, İlhan Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy |
| title | Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy |
| title_full | Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy |
| title_fullStr | Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy |
| title_full_unstemmed | Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy |
| title_short | Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy |
| title_sort | correction: efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under cdk 4/6 inhibitor therapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969671/ https://www.ncbi.nlm.nih.gov/pubmed/36849943 http://dx.doi.org/10.1186/s12885-023-10662-3 |
| work_keys_str_mv | AT karacincengiz correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT oksuzogluberna correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT demirciayse correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT keskinkılıcmerve correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT baytemurnaziyetkose correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT yılmazfunda correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT selvioguzhan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT erdemdilek correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT avsaresin correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT paksoynail correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT demirnecla correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT goksusemasezgin correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT turkersema correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT bayramertugrul correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT celebiabdussamet correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT yılmazhatice correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT kuzuomerfaruk correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT kahramanseda correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT gokmenivo correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT sakinabdullah correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT alkanali correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT nayırerdinc correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT ugraklımuzafer correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT acaromer correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT erturkismail correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT demirhacer correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT aslanferit correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT sonmezozlem correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT korkmaztaner correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT celayirozdemelisa correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT karadagibrahim correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT kayıkcıogluerkan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT sakalarteoman correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT oktemilkernihat correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT erentulay correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT erulenes correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT mocanedaeylemer correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT kalkanziya correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT yıldırımnilgun correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT ergunyakup correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT akagunduzbaran correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT karakayaserdar correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT kutengin correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT tekerfatih correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT demirelburcincakan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT karaboyunkubilay correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT almuradovaelvina correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT unalolcunumit correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT oymanabdilkerim correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT isıkdeniz correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT okuturkerem correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT oztosunbugra correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT gulbagcıburcubelen correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT kalendermehmetemin correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT sahinelif correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT seyyarmustafa correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT ozdemirozlem correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT selcukbiricikfatih correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT kanıtezmetin correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT dedeisa correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT gumusmahmut correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT gokmenerhan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT yarenarzu correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT menekseserkan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT ebincsenar correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT aksoysercan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT imamoglugokseninanc correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT altınbasmustafa correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT cetinbulent correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT ulucbasakoyan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT erozlem correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT karadurmusnuri correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT erdoganatikepınar correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT artacmehmet correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT tanrıverdiozgur correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT cicinirfan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT sendurmehmetalinahit correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT oktayesin correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT bayogluibrahimvedat correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT paydassemra correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT aydıneradnan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT salimderyakıvrak correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT geredelicaglayan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT yavuzsentugba correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT doganmutlu correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy AT hacıbekirogluilhan correctionefficacyofsubsequenttreatmentsinpatientswithhormonepositiveadvancedbreastcancerwhohaddiseaseprogressionundercdk46inhibitortherapy |